Criterion Energy Partners is aiming to be a next-gen energy company. Photo via Getty Images

Sean Marshall and Danny Rehg founded Criterion Energy Partners in 2020 with the hope that geothermal energy could be the cleaner, safer wave of the future. Less than three years later, the team is close to making their plan a reality thanks to a geothermal well that they hope to drill this year.

Entrepreneurship wasn’t always part of the plan for either partner. When Marshall enrolled in the MBA program at Rice University’s Jones School of Business in 2016, he had a successful career at Credit Suisse and had his eye set on a future political career. But then he met classmate Rehg, whose background was in petroleum engineering. Their wives were both attorneys in the Houston district attorney’s office and the couples became fast friends. They also realized that, as Marshall now puts it, Rehg knew how to drill wells and he knew how to make deals.

In the ensuing years, both Rehg and Marshall's careers evolved and, eventually, the pair started looking for other opportunities. That’s when they read an article in Rolling Stone about geothermal energy.

“It was really a place where it really felt like this was something we were put here to do,” says Marshall.

Marshall and Rehg spent the ensuing months “like rats in a dumpster” learning about the players and opportunities in the geothermal industry and built from there. They learned about Pleasant Bayou Power Plant, a 1989 geothermal energy project based in Brazoria County that was backed by the U.S. Department of Energy.

Last summer, Criterion Energy Partners, a member of Greentown Houston, closed on a 10,000-acre lease around the site of Pleasant Bayou.

"We hope by the end of this year we will be generating electrons,” says Marshall.

Though the company has a patented technology that connects wells to the grid, called Criterion Geothermal System, Marshall says that some of the best advice he’s gotten was, “Don’t fall in love with your technology; fall in love with the problem.” The 2021 Texas freeze reminded the founders what that was.

“People were looking for cleaner, lower-emission power sources and [there was] a need for energy resiliency,” says Marshall, explaining that the freeze created an ideal situation for the company, as people began to think more outside the grid.

The year 2022 was a big one for Criterion Energy Partners. Oil and gas powerhouse Patterson-UTI invested in the company, followed by funding from the Department of Energy. The money not only allowed Criterion Energy Partners to lease their land, they are also now paying 12 salaries, including those of the founders. The team offices in The Cannon’s Esperson coworking space.

“Our mission is to make geothermal commercially viable everywhere,” says Marshall. “I still believe in that.”

However, Criterion Energy Partners may be even bigger than proving an alternative energy source. Marshall says that geothermal is the foundation on which they are building “a next-generation energy company.” Criterion Energy Partners could be the more stable basis for a whole new energy system.

Sean Marshall and Danny Rehg founded Criterion Energy Partners in 2020. Photos courtesy

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Nominations are now open for the 2025 Houston Innovation Awards

Calling All Innovators

Calling all Houston innovators: The Houston Innovation Awards return this fall to celebrate the best and brightest in the Houston innovation ecosystem right now.

Presented by InnovationMap, the fifth annual Houston Innovation Awards will take place November 5 at TMC Helix Park.

The awards program will honor the top startups and innovators in Houston across 10 categories, and we're asking you to nominate the most deserving Houston innovators and innovative companies today.

This year's categories are:

  • Minority-founded Business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation.
  • Female-founded Business, honoring an innovative startup founded or co-founded by a woman.
  • Energy Transition Business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond.
  • Health Tech Business, honoring an innovative startup within the health and medical technology sectors.
  • Deep Tech Business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges, including those in the AI, robotics, and space sectors.
  • Startup of the Year (People's Choice), honoring a startup celebrating a recent milestone or success. The winner will be selected by the community via an interactive voting experience.
  • Scaleup of the Year, honoring an innovative later-stage startup that's recently reached a significant milestone in company growth.
  • Incubator/Accelerator of the Year, honoring a local incubator or accelerator that is championing and fueling the growth of Houston startups.
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support budding entrepreneurs.
  • Trailblazer, honoring an innovator who's made a lasting impact on the Houston innovation community.

Nominations may be made on behalf of yourself, your organization, and other leaders in the local innovation scene. The nomination period closes on August 31, so don't delay — nominate today at this link, or fill out the embedded form below.

Our panel of esteemed judges will review the nominations, and determine the finalists and winners. Finalists will be unveiled on September 30, and the 2025 Houston Innovation Awards winners will be announced live at our event on November 5.

Tickets will go on sale this fall. Stay tuned for that announcement, as well as more fanfare leading up to the 2025 Houston Innovation Awards.

Nominate now:

Interested in Innovation Awards sponsorship opportunities? Please contact sales@innovationmap.com.

MD Anderson launches $10M collaboration to advance personalized cancer treatment tech

fighting cancer

The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have announced a strategic collaboration to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.

The technology will be used as a tool for personalized cancer treatments and drug screening efforts, according to a release from MD Anderson. TOPPAN has committed $10 million over five years to advance the joint research activities.

“The strategic alliance with MD Anderson paves a promising path toward personalized cancer medicine," Hiroshi Asada, head of the Business Innovation Center at TOPPAN Holdings, said in a news release.

Invivoid is capable of establishing organoid models directly from patient biopsies or other tissues in a way that is faster and more efficient. Researchers may be able to test a variety of potential treatments in the laboratory to understand which approach may work best for the patient, if validated clinically.

“Organoids allow us to model the three-dimensional complexity of human cancers in the lab, thus allowing us to engineer a powerful translational engine—one that could not only predict how patients will respond to therapy before treatment begins but also could help to reimagine how we discover and validate next-generation therapies," Dr. Donna Hansel, division head of pathology and laboratory medicine at MD Anderson, added in the news release. “Through this collaboration, we hope to make meaningful progress in modeling cancer biology for therapeutic innovation.”

The collaboration will build upon preclinical research previously conducted by MD Anderson and TOPPAN. The organizations will work collaboratively to obtain College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certifications for the technology, which demonstrate a commitment to high-quality patient care. Once the certifications are obtained, they plan to conduct observational clinical studies and then prospective clinical studies.

“We believe our proprietary invivoid 3D cell culture technology, by enabling the rapid establishment of organoid models directly from patient biopsies, has strong potential to help identify more effective treatment options and reduce the likelihood of unnecessary therapies,” Asada added in the release. “Through collaboration on CAP/CLIA certification and clinical validation, we aim to bring this innovation closer to real-world patient care and contribute meaningfully to the advancement of cancer medicine."